Table II.
Repeated measures of the ANOVA results for red blood cell counts (RBCs), hemoglobin (Hb), hematocrit (Hct), and platelet counts (PLTs).
| Time Points of Observation, d | RBCs |
P | Hb |
P | Hct |
P | PLTs |
P | PLTs in Nonsepsis Patients |
P | PLTs in Severe Sepsis Patients |
P | ||||||
| LTG | CTG | LTG | CTG | LTG | CTG | LTG | CTG | LTG | CTG | LTG | CTG | |||||||
| 0⁎ | 3.29 (0.71) | 3.34 (0.59) | 0.751 | 98.10 (19.31) | 101.68 (17.77) | 0.410 | 0.31 (0.06) | 0.31 (0.06) | 0.505 | 193.05 (102.88) | 177.32 (131.27) | 0.563 | 232.77 (98.60) | 245.83 (142.67) | 0.721 | 124.20 (69.80) | 100.25 (53.58) | 0.291 |
| 1st | 3.18 (0.67) | 3.18 (0.58) | 0.995 | 97.05 (18.06) | 97.41 (17.68) | 0.930 | 0.30 (0.06) | 0.30 (0.06) | 0.831 | 183.78 (107.01) | 155.82 (112.63) | 0.470 | 222.92 (102.79) | 225.00 (117.22) | 0.951 | 113.60 (66.65) | 96.81 (54.60) | 0.448 |
| 3rd | 3.16 (0.63) | 3.18 (0.54) | 0.841 | 96.39 (17.24) | 98.35 (16.14) | 0.620 | 0.30 (0.06) | 0.30 (0.07) | 0.356 | 174.17 (93.57) | 164.21 (118.82) | 0.686 | 214.19 (89.13) | 225.44 (126.66) | 0.728 | 104.80 (51.97) | 95.31 (62.33) | 0.650 |
| 5th | 3.09 (0.69) | 3.29 (0.50) | 0.168 | 94.20 (17.61) | 100.68 (17.76) | 0.118 | 0.29 (0.06) | 0.31 (0.05) | 0.117 | 164.29 (90.65) | 158.29 (115.26) | 0.802 | 206.39 (81.96) | 216.22 (116.00) | 0.743 | 91.33 (49.90) | 93.13 (73.63) | 0.938 |
| 7th | 3.10 (0.62) | 3.27 (0.50) | 0.163 | 94.12 (15.69) | 101.35 (16.18) | 0.054 | 0.29 (0.05) | 0.31 (0.05) | 0.130 | 161.76 (96.32) | 161.53 (118.26) | 0.993 | 207.12 (88.08) | 218.39 (122.73) | 0.724 | 83.13 (47.00) | 97.56 (73.51) | 0.523 |
| 9th | 2.95 (0.58) | 3.31 (0.56) | 0.008 | 88.85 (15.58) | 101.82 (16.82) | 0.001 | 0.28 (0.05) | 0.31 (0.06) | 0.006 | 141.27 (88.63) | 151.88 (108.61) | 0.643 | 181.31 (83.16) | 211.50 (109.14) | 0.304 | 71.87 (44.24) | 84.81 (58.21) | 0.493 |
| 11th | 2.88 (0.63) | 3.26 (0.66) | 0.015 | 87.00 (15.58) | 99.24 (18.76) | 0.004 | 0.27 (0.05) | 0.30 (0.06) | 0.004 | 126.68 (83.35) | 145.85 (114.17) | 0.406 | 163.65 (79.60) | 209.33 (120.56) | 0.137 | 62.80 (40.30) | 74.44 (43.90) | 0.449 |
| 13th | 2.88 (0.63) | 3.18 (0.65) | 0.042 | 87.71 (16.48) | 97.82 (20.47) | 0.020 | 0.27 (0.05) | 0.30 (0.06) | 0.037 | 126.68 (88.60) | 139.94 (112.03) | 0.569 | 164.04 (87.95) | 199.67 (120.90) | 0.264 | 61.93 (39.10) | 72.75 (44.16) | 0.477 |
| 15th | 2.86 (0.62) | 3.15 (0.63) | 0.050 | 87.76 (16.81) | 96.74 (20.81) | 0.042 | 0.27 (0.05) | 0.29 (0.06) | 0.046 | 125.00 (91.23) | 135.15 (113.48) | 0.669 | 163.27 (91.33) | 193.61 (124.65) | 0.356 | 58.67 (38.06) | 69.38 (44.79) | 0.480 |
P values represent the statistical differences between two groups at various time points of observation.
CTG, combined treatment group; LTG, linezolid treatment group.
⁎
0 indicates the initial day before treatment.